In previous studies, 18-methoxycoronaridine (18-MC), a novel iboga alkaloid
congener, has been found to decrease the intravenous self-administration o
f morphine and cocaine in rats. In the present study, 18-MC (1-40 mg/kg, i.
p.) dose-dependently decreased the i.v. self-administration of methamphetam
ine and nicotine. As in the previous studies, drug self-administration was
reduced for greater than or equal to 24 h after the highest dose of 18-MC.
A comparison of 18-MC's interactions with all four drugs of abuse studied s
o far indicated that 18-MC is least effective in decreasing methamphetamine
self-administration and most potent in decreasing nicotine self-administra
tion. The results suggest that a nicotinic antagonist action of 18-MC contr
ibutes to its putative anti-addictive efficacy. NeuroReport 11:2013-2015 (C
) 2000 Lippincott Williams & Wilkins.